Sanguine Byun Selected Research

5-deoxykaempferol

4/2010

5-deoxykaempferol plays a potential therapeutic role by targeting multiple signaling pathways in skin cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sanguine Byun Research Topics

Disease

23	Neoplasms (Cancer) 02/2020 - 07/2008
6	Carcinogenesis 06/2019 - 07/2008
5	Skin Neoplasms (Skin Cancer) 01/2014 - 07/2008
3	Inflammation (Inflammations) 01/2022 - 02/2013
3	Ovarian Neoplasms (Ovarian Cancer) 01/2014 - 10/2012
2	Virus Diseases (Viral Diseases) 05/2022 - 01/2021
2	Human Influenza (Influenza) 01/2021 - 01/2021
2	Colonic Neoplasms (Colon Cancer) 01/2016 - 01/2013
2	Melanoma (Melanoma, Malignant) 01/2014 - 12/2013
1	Rheumatoid Arthritis 01/2022
1	Synovitis 01/2022
1	Infections 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2015
1	Hypertensive Encephalopathy 12/2013
1	Hypertension (High Blood Pressure) 12/2013
1	Hypokalemia 12/2013
1	Prostatic Neoplasms (Prostate Cancer) 10/2013
1	Neoplasm Metastasis (Metastasis) 10/2013
1	Colorectal Neoplasms (Colorectal Cancer) 10/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2013
1	Lung Neoplasms (Lung Cancer) 07/2013
1	Edema (Dropsy) 02/2013
1	Obesity 01/2013
1	Chronic Disease (Chronic Diseases) 01/2013
1	Pheochromocytoma 06/2011

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 05/2017 - 12/2013
4	PhytochemicalsIBA 09/2015 - 04/2010
3	VaccinesIBA 05/2022 - 01/2021
3	Phosphotransferases (Kinase)IBA 11/2017 - 01/2013
3	Cisplatin (Platino)FDA LinkGeneric 01/2014 - 10/2012
2	Capsaicin (Zostrix)FDA Link 06/2019 - 09/2010
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2015 - 07/2013
2	isoangustone AIBA 12/2013 - 10/2013
2	LuteolinIBA 10/2013 - 03/2010
2	ErbB Receptors (EGF Receptor)IBA 07/2013 - 09/2010
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2013 - 09/2010
2	myricetinIBA 05/2010 - 07/2008
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	(8)-shogaolIBA 01/2022
1	Vaccine AdjuvantsIBA 01/2021
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2021
1	CaspasesIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	Hemagglutinins (Hemagglutinin)IBA 01/2021
1	aluminum sulfate (alum)IBA 01/2021
1	AntigensIBA 01/2021
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2021
1	Viral ProteinsIBA 01/2021
1	Therapeutic UsesIBA 02/2020
1	piperlongumineIBA 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	QuercetinIBA 10/2019
1	capsiateIBA 06/2019
1	capsanthinIBA 06/2019
1	Amino Acids FDA Link 06/2019
1	dihydrocapsaicinIBA 06/2019
1	Translationally-Controlled 1 Tumor ProteinIBA 05/2017
1	acetovanillone (apocynin)IBA 01/2016
1	sulphorapheneIBA 01/2016
1	CateninsIBA 01/2016
1	IsothiocyanatesIBA 01/2016
1	Glutathione (Reduced Glutathione)IBA 01/2016
1	sulforaphaneIBA 01/2016
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2016
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2015
1	Gemcitabine FDA Link 12/2015
1	gingerenone AIBA 09/2015
1	DiarylheptanoidsIBA 01/2014
1	hirsutenoneIBA 01/2014
1	Apoptosis Inducing FactorIBA 01/2014
1	acacetinIBA 01/2014
1	Adenosine Triphosphate (ATP)IBA 01/2014
1	CyclinsIBA 12/2013
1	FlavonoidsIBA 12/2013
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 12/2013
1	Matrix Metalloproteinases (MMPs)IBA 10/2013
1	Sweetening Agents (Sweeteners)IBA 10/2013
1	X-Linked Inhibitor of Apoptosis ProteinIBA 08/2013
1	3,3',4,5'-tetrahydroxystilbeneIBA 08/2013
1	Tyrosine Kinase InhibitorsIBA 07/2013
1	Gefitinib (Iressa)FDA Link 07/2013
1	Ubiquitin-Specific ProteasesIBA 07/2013
1	src-Family KinasesIBA 02/2013
1	ApigeninIBA 02/2013
1	quercetagetinIBA 01/2013
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2013
1	Transcription Factors (Transcription Factor)IBA 01/2013
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2013
1	kaempferolIBA 06/2011
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 06/2011
1	daidzeinIBA 04/2011
1	GenisteinIBA 04/2011
1	Biological ProductsIBA 04/2011

Therapy/Procedure

5	Therapeutics 11/2017 - 01/2013
1	Combination Drug Therapy (Combination Chemotherapy) 12/2015
1	Chemoprevention 01/2014
1	Oral Administration 10/2013
1	Intravenous Injections 10/2013